AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Fpgli M 0.5 Tablet PR

Prescription Icon
Prescription Required

Marketer

Azkka Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview Fpgli M 0.5 Tablet PR

DiabetaComb 0.5mg tablets are classified as antidiabetic agents, combining two medications for adult type 2 diabetes management. This medication aids in regulating blood glucose in diabetic patients. DiabetaComb 0.5mg tablets should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar responses. Continuous use is vital, even with controlled blood sugar or feeling well; abrupt cessation can elevate blood glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication is a component of a comprehensive treatment plan incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are crucial for prevention. Alcohol consumption should be minimized due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or breastfeeding individuals should seek medical advice before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.

Uses of Fpgli M 0.5 Tablet PR

Managing type 2 diabetes

Major Benefits of Fpgli M 0.5 Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidance. Consume Fpgli M 0.5 Tablet PR with a meal.

Common Side effects of Fpgli M 0.5 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Fpgli M 0.5 Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidelines. Take Fpgli M 0.5 Tablet PR with food.

How Fpgli M 0.5 Tablet PR works:

Fpgli M 0.5 Tablet PR combines glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin sensitivity throughout the body.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Fpgli M 0.5 Tablet PR with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The medication Fpgli M 0.5 Tablet PR may pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescription. Patient consultation with their doctor is recommended.

Breast feedingBreast feedingUNSAFE

Administering Fpgli M 0.5 Tablet PR to breastfeeding mothers is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Fpgli M 0.5 Tablet PR cautiously, potentially requiring a modified dosage. Severe kidney disease contraindicates its use. Consult your physician. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Fpgli M 0.5 Tablet PR cautiously, potentially requiring dose modification. Consult a physician. For those with mild to moderate liver disease, initiate treatment with a low Fpgli M 0.5 Tablet PR dosage; however, it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Fpgli M 0.5 Tablet PR :

Should you forget to take your Fpgli M 0.5 Tablet PR, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Fpgli M 0.5 Tablet PR

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Fpgli M 0.5 Tablet PR

Retain this medication within its original, sealed container or packaging. Store as directed on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and others.
Indeed, Fpgli M 0.5 Tablet PR carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. This complication, also termed MALA (Metformin-associated lactic acidosis), is infrequent but a significant concern, particularly for individuals with pre-existing kidney impairment, the elderly, or those consuming substantial alcohol. Symptoms may manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, vomiting, abdominal discomfort, or a slow pulse. Should these symptoms appear, discontinue Fpgli M 0.5 Tablet PR use and seek immediate medical attention.
Fpgli M 0.5 Tablet PR contains glimepiride and metformin, two medications used together to manage type 2 diabetes mellitus in adults. This therapy enhances blood sugar control when combined with a healthy diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin decreases hepatic glucose production and increases insulin responsiveness. This formulation is unsuitable for type 1 diabetes mellitus.
Fpgli M 0.5 Tablet PR may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but potentially serious adverse reactions such as lactic acidosis can occur. Prolonged treatment may result in vitamin B12 deficiency.
Indeed, prolonged use of Fpgli M 0.5 Tablet PR can lead to Vitamin B12 deficiency. This medication hinders the stomach's absorption of Vitamin B12. Left unaddressed, this deficiency may result in anemia, neurological complications, including tingling and numbness in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and balance impairment (ataxia). To mitigate these risks, supplemental Vitamin B12 intake, at least annually, has been proposed by some studies.
Indeed, Fpgli M 0.5 Tablet PR can induce hypoglycemia. This low blood sugar condition manifests as nausea, headache, irritability, hunger, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying readily available simple sugars, such as glucose tablets, honey, or fruit juice, is strongly recommended.
Combining Fpgli M 0.5 Tablet PR and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia). This combination also raises the likelihood of lactic acidosis.
Fpgli M 0.5 Tablet PR
45
MRP 55
18% off